Forte Biosciences, Inc. (FBRX) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 3 Buy, 3 Hold.
The consensus price target is $65.00, representing an upside of 100.5% from the current price $32.42.
Analysts estimate Earnings Per Share (EPS) of $-9.44 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-12.17 vs est $-9.44 (missed -29%). 2025: actual $-4.71 vs est $-5.10 (beat +7.6%). Analyst accuracy: 85%.
FBRX Stock — 12-Month Price Forecast
$65.00
▲ +100.49% Upside
Average Price Target
Based on 6 Wall Street analysts offering 12-month price targets for Forte Biosciences, Inc., the price target is $65.00.
The average price target represents a +100.49% change from the last price of $32.42.
FBRX Analyst Ratings
Buy
Based on 6 analysts giving stock ratings to Forte Biosciences, Inc. in the past 3 months
EPS Estimates — FBRX
85%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$12.17
vs Est –$9.44
▼ 22.5% off
2025
Actual –$4.71
vs Est –$5.10
▲ 8.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — FBRX
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
